PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
10589941-5	1999	CBF was recorded by the 133Xenon injection technique, and by transcranial Doppler sonography determined mean flow velocity (Vmean) in the middle cerebral artery.	Xenon-133	24-32	CCAAT enhancer binding protein zeta	Homo sapiens	0-3
8373919-2	1993	CBF was measured with the 133xenon inhalation technique in 108 patients and 108 age-matched and gender-matched controls while the subjects were at rest.	Xenon-133	26-34	CCAAT/enhancer binding protein zeta	Rattus norvegicus	0-3
8751623-4	1996	Regional CBF was measured by recording the washout of a bolus of xenon-133 injected through the microcatheter.	Xenon-133	65-74	CCAAT enhancer binding protein zeta	Homo sapiens	9-12
9579496-6	1998	The washout curves from intracarotid 133Xenon injections were used to calculate rCBF before and at the time of carotid occlusion by the half-time (t(1/2)) technique.	Xenon-133	37-45	CCAAT/enhancer binding protein zeta	Rattus norvegicus	80-84
8743121-1	1996	OBJECTIVE: Comparative assessment of sensitivity and specificity of regional Cerebral Blood Flow (rCBF) by 133-Xenon inhalation and quantitative Electroencephalography (qEEG) in patients with Neuropsychiatric Systemic Lupus Erythematosus (NP-SLE).	Xenon-133	107-116	CCAAT/enhancer binding protein zeta	Rattus norvegicus	98-102
7735685-13	1995	In experiments measuring changes in local blood flow in rat skin by a 133xenon clearance technique, intradermal injection of both ADM13-52 (3-300 pmol) and CGRP (0.1-30 pmol) evoked dose-related increases in local blood flow.	Xenon-133	70-78	calcitonin-related polypeptide alpha	Rattus norvegicus	156-160
8454078-3	1993	administered 133Xenon with 3 min clearance recording time for two-dimensionally (hemispheric CBF) and 99m-technetium-hexamethylpropylene amine oxime (99mTC-HMPAO) for three-dimensionally single photon emission computed tomography (SPECT) measurements (rCBF).	Xenon-133	13-21	CCAAT/enhancer binding protein zeta	Rattus norvegicus	93-96
8432218-2	1993	RESEARCH DESIGN AND METHODS: rCBF was measured by the 133Xenon inhalation method in 20 IDDM patients and in 15 healthy control subjects before and after an intravenous injection of ACZ, a carbonic anhydrase inhibitor commonly used to assess cerebrovascular reactivity.	Xenon-133	54-62	CCAAT/enhancer binding protein zeta	Rattus norvegicus	29-33
8454078-3	1993	administered 133Xenon with 3 min clearance recording time for two-dimensionally (hemispheric CBF) and 99m-technetium-hexamethylpropylene amine oxime (99mTC-HMPAO) for three-dimensionally single photon emission computed tomography (SPECT) measurements (rCBF).	Xenon-133	13-21	CCAAT/enhancer binding protein zeta	Rattus norvegicus	252-256
1476267-2	1992	rCBF was measured by the 133Xenon inhalation method.	Xenon-133	25-33	CCAAT/enhancer binding protein zeta	Rattus norvegicus	0-4
1868765-1	1991	The rCBF in a group of 120 patients with cerebrovascular disease (CVD) diagnosed clinically as well as with CT scans and a group of 120 healthy subjects as controls was measured with the 133Xenon inhalation method.	Xenon-133	187-195	CCAAT/enhancer binding protein zeta	Rattus norvegicus	4-8
1868765-4	1991	The areas of rCBF reduction measured with 133Xenon inhalation were larger than the extents of the lesions shown by CT scans in 47 cases of cerebral infarction.	Xenon-133	42-50	CCAAT/enhancer binding protein zeta	Rattus norvegicus	13-17
2374883-2	1990	The 133xenon inhalation method for measuring regional cerebral blood flow (rCBF) can contribute to the understanding of the neural basis of gender differences in brain function.	Xenon-133	4-12	CCAAT/enhancer binding protein zeta	Rattus norvegicus	75-79
2517843-3	1989	SPECT enables the regional cerebral blood flow (rCBF) to be measured, after inhalation or injection of 133-Xenon, on 5 contiguous, 20 mm thick axial sections, with a 14 mm resolution and negligible brain irradiation.	Xenon-133	103-112	CCAAT/enhancer binding protein zeta	Rattus norvegicus	48-52
4010872-2	1985	The rCBF of 54 patients was measured by the Xe133 inhalation method under identical conditions before and 60 min after oral administration of nimodipine.	Xenon-133	44-49	CCAAT/enhancer binding protein zeta	Rattus norvegicus	4-8
3215218-1	1988	The regional cerebral blood flow (rCBF) distribution was measured by 133xenon inhalation using a gamma camera in 18 right-handed volunteers, 6 subjects performing a graphic task (writing numbers in letters) with the right hand, 6 subjects imagining the same task, and 6 subjects were assessed during two rest periods to determine the reproducibility of the technique.	Xenon-133	69-77	CCAAT/enhancer binding protein zeta	Rattus norvegicus	34-38
3545653-7	1987	This finding with renin release stimulation at Xenon133 infusion in the renal artery is of great importance in judging results of investigations concerning renal blood flow and renin when the Xenon wash-out technique is used.	Xenon-133	47-55	renin	Homo sapiens	177-182
3492785-0	1986	Monitoring CBF in clinical routine by dynamic single photon emission tomography (SPECT) of inhaled xenon-133.	Xenon-133	99-108	CCAAT enhancer binding protein zeta	Homo sapiens	11-14
3962688-4	1986	Regional cerebral blood flow (rCBF) was measured directly onto the cortex of the brain by local atraumatic application of 133xenon.	Xenon-133	122-130	CCAAT/enhancer binding protein zeta	Rattus norvegicus	30-34
3545653-0	1987	Increase of plasma renin activity at renal blood flow estimations with the xenon133 wash-out technique in patients with renal artery stenosis.	Xenon-133	75-83	renin	Homo sapiens	19-24
3545653-7	1987	This finding with renin release stimulation at Xenon133 infusion in the renal artery is of great importance in judging results of investigations concerning renal blood flow and renin when the Xenon wash-out technique is used.	Xenon-133	47-55	renin	Homo sapiens	18-23
3877544-1	1985	Regional cerebral blood flow (rCBF) was studied by single photon emission computerized tomography (SPECT) of inhaled xenon-133 in six normal volunteers during various language, articulatory, and control conditions.	Xenon-133	117-126	CCAAT/enhancer binding protein zeta	Rattus norvegicus	30-34
4005072-0	1985	[Evaluations of regional cerebral blood flow (rCBF) by 133Xenon i.v.	Xenon-133	55-63	CCAAT/enhancer binding protein zeta	Rattus norvegicus	46-50
6609739-1	1984	Regional cerebral blood flow (rCBF) was measured by single photon emission tomography, using Xenon-133 inhalation during migraine attacks.	Xenon-133	93-102	CCAAT/enhancer binding protein zeta	Rattus norvegicus	30-34
6424945-1	1984	A rapidly rotating single-photon emission tomograph was used to study regional cerebral blood flow (rCBF) by 133-Xenon inhalation in 18 patients with cluster headache.	Xenon-133	109-118	CCAAT/enhancer binding protein zeta	Rattus norvegicus	100-104
6413315-3	1983	133Xenon-DSPECT provides measurement of regional cerebral blood flow (rCBF in ml/100 g/min) during and after inhalation of 133Xe gas.	Xenon-133	0-8	CCAAT/enhancer binding protein zeta	Rattus norvegicus	70-74
6881926-2	1983	Using the 133xenon intraarterial injection method, rCBF was measured in 254 areas in one hemisphere.	Xenon-133	10-18	CCAAT/enhancer binding protein zeta	Rattus norvegicus	51-55
731237-2	1978	Measurement of the regional cerebral blood flow (rCBF) by the 133Xenon inhalation method and computerised tomography were performed in 25 patients with presenile and senile dementia.	Xenon-133	62-70	CCAAT/enhancer binding protein zeta	Rattus norvegicus	49-53
6410793-1	1983	Using a single-photon emission computed tomographic scanner (SPECT) the authors determined regional cerebral blood flow (rCBF) with inhaled xenon-133, a noninvasive procedure.	Xenon-133	140-149	CCAAT/enhancer binding protein zeta	Rattus norvegicus	121-125
864614-7	1977	Measurement by the 133xenon washout method revealed diphasic blood flow shifts, as a function of the plasma AVP level, between compartment 1 (outer cortex) and compartment 2 (inner cortex and outer medulla) without change in compartment 3 (inner medulla).	Xenon-133	19-27	arginine vasopressin	Canis lupus familiaris	108-111
710363-3	1978	So far as the changes are focal (uni- or multifocal) they can be assessed by external measurement of focal cerebral blood flow (rCBF) with the 133Xenon clearance technique, provided that the detection apparatus used yields a proper spatial and temporal resolution.	Xenon-133	143-151	CCAAT/enhancer binding protein zeta	Rattus norvegicus	128-132